NQGAX | TEDSX | NQGAX / TEDSX | |
Total Expense Ratio | 1.11 | 1.96 | 57% |
Annual Report Gross Expense Ratio | 1.27 | 1.96 | 65% |
Fund Existence | 16 years | 33 years | - |
Gain YTD | 22.056 | 16.637 | 133% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 148M | 9.42B | 2% |
Annual Yield % from dividends | 1.86 | 0.85 | 219% |
Returns for 1 year | 19.53 | 2.93 | 667% |
Returns for 3 years | 72.54 | 28.46 | 255% |
Returns for 5 years | 94.85 | 36.44 | 260% |
Returns for 10 years | 97.04 | 9.22 | 1,053% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYFNX | 93.00 | 0.72 | +0.78% |
Rydex Financial Services A | |||
SHSKX | 68.27 | 0.36 | +0.53% |
BlackRock Health Sciences Opps K | |||
HLMVX | 37.61 | 0.19 | +0.51% |
Harding Loevner Global Equity Inst | |||
SCUVX | 28.74 | 0.05 | +0.17% |
Hartford Schroders US Small Cap Opps A | |||
TCPWX | 14.65 | -0.02 | -0.14% |
Transamerica Capital Growth R6 |